Because Six1 expression induces an EMT both in vitro and in vivo, a phenotype that is primarily associated with basal and claudin low breast cancers, we examined whether its expression was enriched specifically in these subtypes of breast cancer using the previously combined 779 breast tumor dataset [22] and UNC311 dataset [23]. This evidence concerns the gene SIX1 and breast cancer.